BIO FOr CARE: biomarkers of hypertrophic cardiomyopathy development and progression in carriers of Dutch founder truncating MYBPC3 variants—design and status
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1876-6250
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
BIO FOr CARE: biomarkers of hypertrophic cardiomyopathy development and progression in carriers of Dutch founder truncating MYBPC3 variants—design and status ; day:2 ; month:2 ; year:2021 ; pages:1-8
Netherlands heart journal ; (2.2.2021), 1-8
- Urheber
-
Jansen, M.
Christiaans, I.
Crabben, S. N. van der
Michels, M.
Huurman, R.
Hoedemaekers, Y. M.
Dooijes, D.
Jongbloed, J. D. H.
Boven, L. G.
Lekanne Deprez, R. H.
Wilde, A. A. M.
Jans, J. J. M.
Velden, J. van der
Boer, R. A. de
Tintelen, J. P. van
Asselbergs, F. W.
Baas, A. F.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12471-021-01539-w
- URN
-
urn:nbn:de:101:1-2021032621505235264805
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jansen, M.
- Christiaans, I.
- Crabben, S. N. van der
- Michels, M.
- Huurman, R.
- Hoedemaekers, Y. M.
- Dooijes, D.
- Jongbloed, J. D. H.
- Boven, L. G.
- Lekanne Deprez, R. H.
- Wilde, A. A. M.
- Jans, J. J. M.
- Velden, J. van der
- Boer, R. A. de
- Tintelen, J. P. van
- Asselbergs, F. W.
- Baas, A. F.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Improving risk prediction in hypertrophic cardiomyopathy: the key role of Dutch founder variants
Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity: an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant Carriers
MYH7 p.(Arg1712Gln) is pathogenic founder variant causing hypertrophic cardiomyopathy with overall relatively delayed onset
Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy
Preclinical alterations in cardiac energetics amongst sarcomere mutation carriers in hypertrophic cardiomyopathy
Hypertrophic Cardiomyopathy with a Twist
Increased left ventricular torsion in hypertrophic cardiomyopathy mutation carriers with normal wall thickness
Increased left ventricular torsion in hypertrophic cardiomyopathy mutation carriers with normal wall thickness
Diagnosis and management of hypertrophic cardiomyopathy
Clinical Outcome of Hypertrophic Cardiomyopathy in Probands with the Founder Variant c.913_914del in MYBPC3: A Slovenian Cohort Study
Regional myocardial function at preclinical disease stage of hypertrophic cardiomyopathy in female gene variant carriers
A Dutch MYH7 founder mutation, p.(Asn1918Lys), is associated with early onset cardiomyopathy and congenital heart defects
Improving risk prediction in hypertrophic cardiomyopathy: the key role of Dutch founder variants
Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity: an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant Carriers
MYH7 p.(Arg1712Gln) is pathogenic founder variant causing hypertrophic cardiomyopathy with overall relatively delayed onset
Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy
Preclinical alterations in cardiac energetics amongst sarcomere mutation carriers in hypertrophic cardiomyopathy
Hypertrophic Cardiomyopathy with a Twist
Increased left ventricular torsion in hypertrophic cardiomyopathy mutation carriers with normal wall thickness
Increased left ventricular torsion in hypertrophic cardiomyopathy mutation carriers with normal wall thickness
Diagnosis and management of hypertrophic cardiomyopathy
Clinical Outcome of Hypertrophic Cardiomyopathy in Probands with the Founder Variant c.913_914del in MYBPC3: A Slovenian Cohort Study
Regional myocardial function at preclinical disease stage of hypertrophic cardiomyopathy in female gene variant carriers
A Dutch MYH7 founder mutation, p.(Asn1918Lys), is associated with early onset cardiomyopathy and congenital heart defects
Improving risk prediction in hypertrophic cardiomyopathy: the key role of Dutch founder variants
Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity: an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant Carriers
MYH7 p.(Arg1712Gln) is pathogenic founder variant causing hypertrophic cardiomyopathy with overall relatively delayed onset
Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy
Preclinical alterations in cardiac energetics amongst sarcomere mutation carriers in hypertrophic cardiomyopathy
Hypertrophic Cardiomyopathy with a Twist
Increased left ventricular torsion in hypertrophic cardiomyopathy mutation carriers with normal wall thickness
Increased left ventricular torsion in hypertrophic cardiomyopathy mutation carriers with normal wall thickness
Diagnosis and management of hypertrophic cardiomyopathy
Clinical Outcome of Hypertrophic Cardiomyopathy in Probands with the Founder Variant c.913_914del in MYBPC3: A Slovenian Cohort Study
Regional myocardial function at preclinical disease stage of hypertrophic cardiomyopathy in female gene variant carriers